Literature DB >> 6148000

Persistence of tick-borne encephalitis virus in monkeys. VI. Pathomorphology of chronic infection in central nervous system.

M P Frolova, V V Pogodina.   

Abstract

Histological changes were studied in the central nervous system (CNS) of 58 Macaca rhesus monkeys, infected intracerebrally (i.c.) and subcutaneously (s.c.) with tick-borne encephalitis (TBE) virus. Subacute degenerative process in the CNS occurred in 7 monkeys on days 15-24 post-infection (p.i.), while chronic degenerative changes were observed in 5 monkeys examined on days 45, 90, 279, 383, 789 p.i. Pathological changes in the CNS of 11 monkeys correlated with the clinical picture of subacute and chronic encephalitis. Chronic lesions were observed in the CNS of 1 monkey with asymptotic infection. The pathomorphology of the CNS lesions was characterized by progressive development of focal changes of various duration.

Entities:  

Mesh:

Year:  1984        PMID: 6148000

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  4 in total

1.  Impact of direct virus-induced neuronal dysfunction and immunological damage on the progression of flavivirus (Modoc) encephalitis in a murine model.

Authors:  Pieter Leyssen; Jan Paeshuyse; Nathalie Charlier; Alfons Van Lommel; Christian Drosten; Erik De Clercq; Johan Neyts
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

2.  Why does viral RNA sometimes persist after recovery from acute infections?

Authors:  Diane E Griffin
Journal:  PLoS Biol       Date:  2022-06-01       Impact factor: 9.593

3.  Comparative neuropathogenesis and neurovirulence of attenuated flaviviruses in nonhuman primates.

Authors:  Olga A Maximova; Jerrold M Ward; David M Asher; Marisa St Claire; Brad W Finneyfrock; James M Speicher; Brian R Murphy; Alexander G Pletnev
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

4.  Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy.

Authors:  Natalia S Pripuzova; Larissa V Gmyl; Lidiya Iu Romanova; Natalia V Tereshkina; Yulia V Rogova; Liubov L Terekhina; Liubov I Kozlovskaya; Mikhail F Vorovitch; Karina G Grishina; Andrey V Timofeev; Galina G Karganova
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.